COMPARISON OF LONG-TERM OUTCOMES OF PENILE PROSTHESES AND INTRACAVERNOSAL INJECTION THERAPY
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PURPOSE: Intracavernosal injection therapy is one of the most popular therapies for erectile dysfunction today. Yet, most clinicians consider intracavernosal injection a palliative treatment for erectile dysfunction because of the high patient initiated dropout rate. In contrast, penile prostheses appear to offer a more permanent cure for erectile dysfunction. We compare the long-term outcomes of both therapies in contemporaneously treated patients and determine the reasons for failure of each. MATERIALS AND METHODS: Telephone survey and chart review was conducted on the first 115 patients treated with intracavernosal injection and 65 patients undergoing insertion of a penile prosthesis during the same period at our institution. Mean patient age was 57 and 60 years, respectively, and mean followup of all patients was 5.4 years (range of 3.3 to 16). RESULTS: An equal percentage of patients were lost to followup in both groups, including 19% of the intracavernosal injection group and 18% of the penile prosthesis group. Of the intracavernosal injection patients 6 (6%) died during followup and 10 (19%) of the prosthetic patients died (p < 0.05). At the time of contact only 41% of the patients were still using intracavernosal injection. In contrast, 70% of the patients were still sexually active with the prosthesis (p < 0.01). Mean duration of use of the penile prosthetics was 63 months compared to 37 months for intracavernosal injection (p < 0.001). The most common reasons for discontinuing intracavernosal injection were inadequate erections (16 cases), lack of spontaneity (14), side effects (12), lack of partner (10), loss of sexual interest (6) and spontaneous return of normal erections (4). More than half of the patients (61%) who discontinued intracavernosal injection remain sexually active with other therapies, including penile prosthesis in 11, vacuum devices in 4, vascular surgery in 1 and oral medication in 1, and 14 without any therapy. We could not identify any significant clinical parameters that would accurately predict which patients most benefited by the long-term use of intracavernosal injection therapy. In contrast, only 6 patients discontinued use of the implant because of complications (infection, erosion and malfunction) and 7 for reasons independent of the implant (that is lack of partner, loss of sexual interest and co-morbidity). CONCLUSIONS: Intracavernosal injection serves as only a palliative therapy for the majority of patients with erectile dysfunction but there exists a core group who derives long-term satisfaction with its use. The majority of patients who discontinue intracavernosal injection remain sexually active yet do not progress to more invasive or effective therapies. The reason for discontinuing therapies for erectile dysfunction is often unrelated to the actual therapeutic modality. Our findings suggest that further improvements in intracavernosal injection therapy and the development of alternative methods of delivery of vasoactive agents will have only a limited impact on the overall outcome of therapy for erectile dysfunction and that increased attention to issues separate from the erection is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Outcome Analysis of Goal Directed Therapy for Impotence
Jarow, J. P., Nana-Sinkam, P., Sabbagh, M., & Eskew, A. (1996) · The Journal of Urology · doi:10.1097/00005392-199605000-00021 · Cited by 122
Self-citation
Cited by
CARSON, C. C., MULCAHY, J. J., GOVIER, F. E., & AMS 700CX STUDY GROUP (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67364-8 · Cited by 293
Montorsi, F., Rigatti, P., Carmignani, G., Corbu, C., Campo, B., Ordesi, G., Breda, G., Silvestre, P., Giammusso, B., Morgia, G., et al. (2000) · European Urology · doi:10.1159/000020099 · Cited by 229
“We strongly believe that many factors may influence the occurrence of an infection in this particular patient population including operative time and the size of the operative field. In other words, the faster the procedure and the smaller the operative field, the lower the risk of developing an infection. However, we…”
ResultA pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy
Köhler, T. S., Pedro, R., Hendlin, K., Utz, W., Ugarte, R., Reddy, P., Makhlouf, A., Ryndin, I., Canales, B. K., Weiland, D., et al. (2007) · BJU International · doi:10.1111/j.1464-410x.2007.07161.x · Cited by 226
The use of treatments for erectile dysfunction among survivors of prostate carcinoma
Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L., Klein, E. A., Zippe, C., & Kupelian, P. A. (2002) · Cancer · doi:10.1002/cncr.10970 · Cited by 127
“–26 Emotional factors, such as the loss of a partner, longing for more spontaneity, or relationship conflict, are key reasons that men stop using medical therapies.(16,21) The few programs that combine counseling with medical therapies may achieve enhanced satisfaction rates.”
BackgroundWassersug, R., & Wibowo, E. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.04.09 · Cited by 45
Metadata
- Authors
- SEXTON, W. J., BENEDICT, J. F., & JAROW, J. P.
- Venue
- Journal of Urology
- Published
- 1998-03
- Volume
- 159
- Issue
- 3
- Pages
- 811-815
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2074986225
- Cited by
- 73
- References
- 1
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.